Corrigendum: identification and validation of lncrna-snhg17 in lung adenocarcinoma: a novel prognostic and diagnostic indicator

HIGHLIGHTS

  • who: Xinyan Li from the Frontiers Media SA, SwitzerlandDepartment of Pharmacy, Putuo Hospital, Shanghai University of Traditional Chinese Medicine have published the Article: Corrigendum: identification and validation of lncRNA-SNHG17 in lung adenocarcinoma: a novel prognostic and diagnostic indicator, in the Journal: (JOURNAL)

SUMMARY

    CITATION Li X, Yuan Y, Pal M and Jiang X Corrigendum: identification and validation of lncRNA-SNHG17 in lung adenocarcinoma: a novel prognostic and diagnostic indicator. 12:972329. doi: 10.3389/fonc.2022.972329 COPYRIGHT lung adenocarcinoma, inflammatory response-related gene, DNA methylation, ceRNA, immune cell infiltration, drug sensitivity . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?